Since President Trump’s return to office, the revival of American manufacturing is a constant talking point in the news. New tariffs on imports and pro-domestic production policies have prompted many companies to invest heavily in U.S. operations. Major corporations are reshoring production in a bid to adapt to the new conditions they’re confronted with.
Below I’m going to highlight ten companies that have committed massive funds to rebuilding American industry over the past few months.
1) Taiwan Semiconductor Manufacturing Company (TSMC)
Taiwan Semiconductor Manufacturing Company (TSMC) is investing $100 billion to build three advanced semiconductor plants in Arizona, adding to its previous $65 billion commitment under the Biden administration. This expansion will create somewhere between 20,000 and 25,000 high-paying jobs and strengthen U.S. semiconductor production.
The investment aligns with U.S. efforts to reduce reliance on foreign chip supply chains (we saw how risky these are during Covid times) and enhance national security.
2) Siemens
Siemens is investing $285 million to expand U.S. manufacturing, adding new facilities in Fort Worth, Texas, and Pomona, California to produce electrical equipment for AI data centers, industrial, and construction markets.
The investment will create 900+ skilled jobs and is part of Siemens’ long-term U.S. growth strategy, bringing its total American investment to over $100 billion. This move strengthens U.S. industrial capacity and supports the country’s push in AI-driven infrastructure.
3) Apple
Apple is investing $500 billion in the U.S. over the next four years, including opening a 250,000-square-foot AI server manufacturing facility in Houston, Texas, set to open in 2026. This expansion will create 20,000 jobs across AI, R&D, and manufacturing.
The company is also doubling its Advanced Manufacturing Fund to $10 billion to support U.S. innovation. This move will strengthen domestic production and reduces reliance on overseas supply chains.
4) Eli Lilly
Eli Lilly is investing $27 billion to build four new pharmaceutical plants in the U.S., which will double its domestic manufacturing footprint since 2020. The facilities will produce active pharmaceutical ingredients and injectable therapies, including diabetes and weight-loss treatments.
The expansion will create 3,000 high-skilled jobs and 10,000 construction jobs, strengthening the U.S. pharmaceutical supply chain and reducing reliance on foreign production. These new sites are expected to be operational within five years.
5) Syngene International
Syngene International has acquired its first U.S. biologics facility in Baltimore for $36.5 million, expanding its bioreactor capacity from 20,000 to 50,000 liters. The facility, which is set to be operational by late 2025, will enhance Syngene’s large-molecule drug manufacturing and reduce reliance on China.
6) ABB
ABB is investing $120 million to expand its U.S. manufacturing operations, which will boost its production of electrical distribution equipment for data centers, factories, and renewable energy projects. The facilities when these funds will be invested are:
- Selmer, TN: $80M for a new 320,000 sq. ft. facility, increasing capacity by 50% and adding 50 jobs.
- Senatobia, MS: $40M to double the facility size and create 200 additional jobs.
These projects are set for completion by 2026, and this investment reinforces ABB’s commitment to U.S. production, following $500M in investments over the past three years.
7) GE Vernova
GE Vernova is investing $90 million to expand its Schenectady, NY plant, which will boost its gas power and onshore wind turbine production by as much as 30%. The expansion will create 100+ jobs, and strengthens U.S. clean energy manufacturing.
8) Starplus Energy
StarPlus Energy (Stellantis + Samsung SDI) is investing $6.3 billion to build two EV battery plants in Kokomo, Indiana. The first (33 GWh) will open in 2025, and the second (34 GWh) is planned to open in 2027, supplying batteries for 670,000 EVs annually.
The project will create 2,800 jobs, with additional supplier positions. The U.S. DOE has committed a $7.54 billion loan to support production, solidifying Kokomo as a key EV battery hub.
9) Corning Incorporated
Corning has committed to making a number of different investments into U.S. manufacturing, including:
- $900M Solar Facility (Michigan) – Corning is building a solar component plant in Saginaw County, creating 1,100 jobs and strengthening the U.S. solar supply chain (opens 2025).
- $315M Semiconductor Glass Expansion (New York) – This will expand fused silica & ULE glass production, which are essential for semiconductor manufacturing, adding 130 jobs in the process.
- U.S.-Made Solar Panels – Partnering with Suniva & Heliene to produce 100% American-made solar panels.
10) Reckitt Benckiser
Reckitt is investing $200 million in a 310,000 sq. ft. facility in Wilson, NC to produce Mucinex® cold and flu medications. The plant will create 300 jobs and boost domestic supply chain resilience.
By shifting production from Mexico & the UK, Reckitt aims to cut delivery times and meet rising U.S. demand for OTC medications.
